Smoking Does Not Affect Occlusion Rates and Morbidity-Mortality after Pipeline Embolization for Intracranial Aneurysms

References

1. 1.↵
   2. Bonita R

   . Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke 1986;17:831–35 doi:10.1161/01.STR.17.5.831 pmid:3094199

   Abstract/FREE Full Text
2. 2.↵
   2. Juvela S,
   3. Hillbom M,
   4. Numminen H, et al

   . Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke 1993;24:639–46 doi:10.1161/01.STR.24.5.639 pmid:8488517

   Abstract/FREE Full Text
3. 3.↵
   2. Juvela S,
   3. Poussa K,
   4. Porras M

   . Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke 2001;32:485–91 doi:10.1161/01.STR.32.2.485 pmid:11157187

   Abstract/FREE Full Text
4. 4.↵
   2. Knekt P,
   3. Reunanen A,
   4. Aho K, et al

   . Risk factors for subarachnoid hemorrhage in a longitudinal population study. J Clin Epidemiol 1991;44:933–39 doi:10.1016/0895-4356(91)90056-F pmid:1890435

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Kang HS,
   3. Han MH,
   4. Kwon BJ, et al

   . Repeat endovascular treatment in post-embolization recurrent intracranial aneurysms. Neurosurgery 2006;58:60–70; discussion 60–70 doi:10.1227/01.NEU.0000194188.51731.13 pmid:16385330

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Petitti DB,
   3. Wingerd J

   . Use of oral contraceptives, cigarette smoking, and risk of subarachnoid haemorrhage. Lancet 1978;2:234–35 pmid:79030

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Sacco RL,
   3. Wolf PA,
   4. Bharucha NE, et al

   . Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology 1984;34:847–54 doi:10.1212/WNL.34.7.847 pmid:6539860

   Abstract/FREE Full Text
8. 8.↵
   2. Brinjikji W,
   3. Lingineni RK,
   4. Gu CN, et al

   . Smoking is not associated with recurrence and retreatment of intracranial aneurysms after endovascular coiling. J Neurosurg 2015;122:95–100 doi:10.3171/2014.10.JNS141035 pmid:25380112

   CrossRefPubMed
9. 9.↵
   2. Ortiz R,
   3. Stefanski M,
   4. Rosenwasser R, et al

   . Cigarette smoking as a risk factor for recurrence of aneurysms treated by endosaccular occlusion. J Neurosurg 2008;108:672–75 doi:10.3171/JNS/2008/108/4/0672 pmid:18377244

   CrossRefPubMed
10. 10.↵
    2. Wei HJ,
    3. Wang D,
    4. Chen JL, et al

    . Mobilization of circulating endothelial progenitor cells after endovascular therapy for ruptured cerebral aneurysms. Neurosci Lett 2011;498:114–18 doi:10.1016/j.neulet.2011.04.061 pmid:21575677

    CrossRefPubMed
11. 11.↵
    2. Kadirvel R,
    3. Ding YH,
    4. Dai D, et al

    . Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter. Radiology 2014;270:394–99 doi:10.1148/radiol.13130796 pmid:24086073

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Soga Y,
    3. Tomoi Y,
    4. Fujihara M, et al

    . Perioperative and long-term outcomes of endovascular treatment for subclavian artery disease from a large multicenter registry. J Endovasc Ther 2015;22:626–33 doi:10.1177/1526602815590579 pmid:26092540

    Abstract/FREE Full Text
13. 13.↵
    2. Musallam KM,
    3. Rosendaal FR,
    4. Zaatari G, et al

    . Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg 2013;148:755–62 doi:10.1001/jamasurg.2013.2360 pmid:23784299

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Becske T,
    3. Kallmes DF,
    4. Saatci I, et al

    . Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology 2013;267:858–68 doi:10.1148/radiol.13120099 pmid:23418004

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Kallmes DF,
    3. Hanel R,
    4. Lopes D, et al

    . International retrospective study of the Pipeline embolization device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol 2015;36:108–15 doi:10.3174/ajnr.A4111 pmid:25355814

    Abstract/FREE Full Text
16. 16.↵
    2. Chen JX,
    3. Lai LF,
    4. Zheng K, et al

    . Influencing factors of immediate angiographic results in intracranial aneurysms patients after endovascular treatment. J Neurol 2015;262:2115–23 doi:10.1007/s00415-015-7824-2 pmid:26100332

    CrossRefPubMed
17. 17.↵
    2. Song J,
    3. Yeon JY,
    4. Kim JS, et al

    . Delayed thromboembolic events more than 30 days after self-expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clin Neurol Neurosurg 2015;135:73–78 doi:10.1016/j.clineuro.2015.05.013 pmid:26038280

    CrossRefPubMed
18. 18.↵
    2. Zhu YQ,
    3. Li MH,
    4. Lin F, et al

    . Frequency and predictors of endoleaks and long-term patency after covered stent placement for the treatment of intracranial aneurysms: a prospective, non-randomised multicentre experience. Eur Radiol 2013;23:287–97 doi:10.1007/s00330-012-2581-4 pmid:22782569

    CrossRefPubMed
19. 19.↵
    2. Lal BK,
    3. Beach KW,
    4. Roubin GS, et al

    ; CREST Investigators. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol 2012;11:755–63 doi:10.1016/S1474-4422(12)70159-X pmid:22857850

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Matteau A,
    3. Yeh RW,
    4. Camenzind E, et al

    . Balancing long-term risks of ischemic and bleeding complications after percutaneous coronary intervention with drug-eluting stents. Am J Cardiol 2015;116:686–93 doi:10.1016/j.amjcard.2015.05.036 pmid:26187674

    CrossRefPubMed
21. 21.↵
    2. Yeo KK,
    3. Armstrong EJ,
    4. Soni K, et al

    . Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry. EuroIntervention 2015;11:188–95 doi:10.4244/EIJV11I2A33 pmid:26093838

    CrossRefPubMed
22. 22.↵
    2. Zhang YJ,
    3. Iqbal J,
    4. van Klaveren D, et al

    . Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up. J Am Coll Cardiol 2015;65:1107–15 doi:10.1016/j.jacc.2015.01.014 pmid:25790882

    CrossRefPubMed
23. 23.↵
    2. Anderson CS,
    3. Feigin V,
    4. Bennett D, et al

    ; Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS) Group. Active and passive smoking and the risk of subarachnoid hemorrhage: an international population-based case-control study. Stroke 2004;35:633–37 doi:10.1161/01.STR.0000115751.45473.48 pmid:14752125

    Abstract/FREE Full Text
24. 24.↵
    2. Kim CK,
    3. Kim BJ,
    4. Ryu WS, et al

    . Impact of smoking cessation on the risk of subarachnoid haemorrhage: a nationwide multicentre case control study. J Neurol Neurosurg Psychiatry 2012;83:1100–03 doi:10.1136/jnnp-2012-302538 pmid:22935539

    Abstract/FREE Full Text